Skip to content

Pilot study to test a nursing-led microtraining program for dyspnea management in patients with left heart failure

Pilot study to test a nursing-led microtraining program for dyspnea management in patients with left heart failure - MiDyLi

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039511
Enrollment
10
Registered
2026-03-23
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50.1

Interventions

Group 1: Patients with left heart failure and dyspnea in an intensive care unit. This group receives a brief training session on managing dyspnea (15–20 min.). Participants are then given an evaluatio

Sponsors

Herz- und Diabeteszentrum NRW, Universitätsklinikum der Ruhr- Universität Bochum; Medizinische Fakultät OWL (Universität Bielefeld)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study includes patients who - are being treated in the A 1.2 cardiac intensive care unit at HDZ-NRW; - have medically diagnosed left ventricular failure = NYHA Class II; - have reported dyspnea intensity =3 on a numerical rating scale (NRS) (0 = no dyspnea, 10 = maximum dyspnea) at least once during their stay in the cardiac intensive care unit; - have provided informed written consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they - have a diagnosis or diagnoses of other conditions that, independently of heart failure, cause significant dyspnea or impaired breathing and/or dyspnea (e.g., bronchial carcinoma, pulmonary hypertension, chronic obstructive pulmonary disease), provided that these conditions are the cause of the current dyspnea; - have an acute or chronic neurological condition that may impair cognitive function (e.g., delirium, dementia); - have impaired consciousness, defined as a Richmond Agitation and Sedation Scale (RASS) score <-1 at the time of recruitment; - are unable to sufficiently understand the study information and the informed consent form, even with the assistance of an interpreter; - lack the capacity to consent or have not provided consent to participate in the study; - have already received the micro-training during a previous hospital stay; - are in the process of dying.

Design outcomes

Primary

MeasureTime frame
Duration of individual micro-training sessions (immediately after training, training documentation); recruitment rate (ongoing, recruitment log); dropout rate (ongoing, recruitment log); dyspnea intensity (before training and 2–5 days after training; VAS and 7-point Likert scale)

Secondary

MeasureTime frame
Challenges and barriers from the perspective of the trainer (immediately after training, training documentation); subjective dyspnea management (2–5 days after training, 4-point Likert scale); acceptance and comprehensibility of microtraining (immediately after microtraining, 4-point Likert scale)

Countries

Germany

Contacts

Public ContactLara Konstanty

Herz- und Diabeteszentrum NRW, Universitätsklinikum der Ruhr- Universität Bochum; Medizinische Fakultät OWL (Universität Bielefeld)

lkonstanty@hdz-nrw.de+49 5731 971800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026